// App-Quantinova.ai

4442 : Genomic Profiles of Bone Marrow (BM) Clonal Plasma Cells (PCs) Vs Circulating Tumor Cells (CTCs) and Extramedullary (EM) Plasmacytomas in Multiple Myeloma (MM)

Researchers

Presenter

  • Bruno Paiva

Principal Investigators

  • Rafael Valdes-Mas

  • Diego Alignani

  • Miguel Garcia

  • Leire Burgos

  • Diana Alvarez Puente

  • Xabier Agirre

  • Felipe Prosper

  • Carlos Lopez-Otin

  • Jesus San Miguel

Medical Centers

  • Centro de Investigacion Medica Aplicada, University of Navarra, Clinica Universidad de Navarra, Pamplona, Spain

  • Instituto Universitario de Oncologia (IUOPA), Universidad de Oviedo, Departamento de Bioquimica y Biologia Molecular, Oviedo, Spain

  • n Medica Aplicada, Pamplona, Spain

  • Instituto Universitario de Oncologia, Universidad de Oviedo, Oviedo, Spain

  • Clinica Universidad de Navarra, Pamplona, Spain

  • CIMA/UNAV/IDISNA, Pamplona, Spain

Locations

  • Spain

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Multiple Myeloma

  • Plasmacytoma

Biomarkers

  • AT-rich interactive domain 5B

  • B-Raf proto-oncogene, serine/threonine kinase

  • Circulating tumor cells

  • Cyclin D1

  • Histone-lysine N-methyltransferase 2A

  • KRAS proto-oncogene, GTPase

Drug/Treatment

  • Trastuzumab

Outcome

  • N/A


Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim